Haemonetics Corp (HAE)

EBITDA Margin

19.32%

TTM · Period ending:

HAE logo

HAE EBITDA Margin

Latest reported19.32%
HAE TTM EBITDA Margin (100.00% → 19.32%)
High-resolution chart · PNG

HAE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Haemonetics Corp EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
19.3203%
21.0059%
28.4368%
28.2057%
27.9898%
26.6878%
24.8465%
24.1442%
22.8888%
23.0608%
23.221%
22.5397%
23.3243%
22.308%
22.0659%
22.3513%
21.482%
18.8787%
19.2586%
19.6643%
20.2544%
22.5449%
24.1963%
24.8569%
26.0448%
27.9826%
25.8133%
24.6802%
23.0453%
19.9429%
18.5516%
15.3017%
15.0395%
16.9819%
15.5311%
17.9026%
18.1241%
14.5517%
15.3759%
15.0838%
14.4767%
15.6537%
13.5522%
10.9468%
7.5688%
6.706%
9.1715%
9.0278%
10.1179%
9.4151%
9.8942%
11.5209%
10.2906%
10.9366%
11.0132%
10.7074%
12.4536%
14.0424%
15.1005%
15.8763%
17.68%
19.8023%
16.2431%
17.7541%
19.2508%
19.4046%
21.3342%
21.4366%
19.6325%
17.1377%
18.3674%
16.2659%
15.3434%
15.314%
16.5658%
16.7552%
18.7491%
20.5884%
26.5129%
32.5745%
31.7098%
31.4564%
23.8944%
19.4636%
21.3915%
22.8153%
22.6942%
23.138%
22.2929%
20.9357%
19.2893%
18.9265%
18.9121%
19.5607%
24.1863%
20.4143%
22.5239%
27.9099%
30.4852%
34.6937%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.